NUR-SULTAN. KAZINFORM – Kunsulu Zakarya, Director General of the Research Institute for Biological Safety Problems, revealed when the third stage of clinical trials of Kazakhstan’s QazCovid-in (QazVac) vaccine will be finished, Kazinform correspondent reports.